uniQure (QURE) Enterprise Value (2015 - 2026)
uniQure (QURE) recorded quarterly Enterprise Value of -$586.6 million in Q1 2026, up 5.78% quarter-over-quarter from -$622.5 million in Q4 2025, and down 43.41% on a YoY basis from -$1.0 billion in Q1 2025.
uniQure (QURE) Enterprise Value (2015 - 2026) Analysis & Trends
uniQure's Enterprise Value history runs 12 years deep, the most recent figure standing at -$586.6 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 43.41% year-over-year to -$586.6 million; the TTM figure through Mar 2026 stood at -$586.6 million (down 43.41% YoY), while the FY2025 annual figure was -$622.5 million, down 69.39% from the prior year.
- Enterprise Value was -$586.6 million for Q1 2026 at uniQure, up from -$622.5 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$315.3 million in Q1 2023 to a low of -$694.2 million in Q3 2025.
- Historically, Enterprise Value has averaged -$506.6 million across 5 years, with a median of -$524.4 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Enterprise Value tumbled 101.25% in 2022, then soared 40.52% in 2024.
- A 5-year view of Enterprise Value shows it stood at -$352.8 million in 2022, then tumbled by 75.12% to -$617.9 million in 2023, then jumped by 40.52% to -$367.5 million in 2024, then plunged by 69.39% to -$622.5 million in 2025, then gained by 5.78% to -$586.6 million in 2026.
- The last three Enterprise Value figures came in at -$586.6 million (Q1 2026), -$622.5 million (Q4 2025), and -$694.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn | -586.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -586.55 Mn |
| Dec 31, 2025 | -622.54 Mn |
| Sep 30, 2025 | -694.25 Mn |
| Jun 30, 2025 | -376.97 Mn |
| Mar 31, 2025 | -409.01 Mn |
| Dec 31, 2024 | -367.52 Mn |
| Sep 30, 2024 | -435.24 Mn |
| Jun 30, 2024 | -524.43 Mn |
| Mar 31, 2024 | -555.68 Mn |
| Dec 31, 2023 | -617.89 Mn |
| Sep 30, 2023 | -658.91 Mn |
| Jun 30, 2023 | -628.59 Mn |
| Mar 31, 2023 | -315.34 Mn |
| Dec 31, 2022 | -352.84 Mn |
| Sep 30, 2022 | -440.31 Mn |
| Jun 30, 2022 | -500.52 Mn |
| Mar 31, 2022 | -524.89 Mn |
| Dec 31, 2021 | -556.26 Mn |
| Sep 30, 2021 | -578.46 Mn |
| Jun 30, 2021 | -677.33 Mn |